Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00827255 · ClinicalTrials.gov registry record
Physician's Evaluation of Cyclosporine Ophthalmic Emulsion 0.05%
A clinical trial, sponsored by Allergan.
- Completed
- Registry status
- 35
- Enrollment target
NCT00827255 is a clinical trial that has completed, run by Allergan. The registered enrollment target is 35 participants.
The verdict
NCT00827255 has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
Study Summary
The objective of this retrospective chart review is to evaluate the patient characteristics, treatment variations and efficacy of a second trial of Cyclosporine Ophthalmic Emulsion 0.05% therapy in chronic dry eye patients who were initially treated with Cyclosporine Ophthalmic Emulsion 0.05% but discontinued use after less than 12 weeks of treatment.
Interventions
- DRUG Cyclosporine Ophthalmic Emulsion 0.05%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2009-01 |
| Est. Completion | 2009-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00827255
The ClinicalTrials.gov registry entry for NCT00827255 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cyclosporine Ophthalmic Emulsion 0.05% is the first listed.
NCT00827255 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00827255 about?
NCT00827255 is a clinical study titled "Physician's Evaluation of Cyclosporine Ophthalmic Emulsion 0.05%". The objective of this retrospective chart review is to evaluate the patient characteristics, treatment variations and efficacy of a second trial of Cyclosporine Ophthalmic Emulsion 0.05% therapy in chronic dry eye patients who were initially treated with Cyclosporine Ophthalmic Emulsion 0.05% but di...
What is the current status of trial NCT00827255?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2009-01. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00827255?
The interventions under investigation include: Cyclosporine Ophthalmic Emulsion 0.05% (DRUG).
Who is sponsoring clinical trial NCT00827255?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.